Bausch + Lomb (BLCO) said Thursday that a go-private deal with a third-party buyer won't materialize at this time.
The deal was one of the options being explored to complete a full separation from Bausch Health (BHC), Bausch + Lomb said.
"After engagement with potential buyers, that process is complete, and will not result in a transaction at this time," Bausch + Lomb said, adding that "full separation remains the goal."
Bausch + Lomb shares were falling past 8% in recent trading, and Bausch Health was down nearly 4%.
Price: 16.29, Change: -1.46, Percent Change: -8.23
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.